Study to Evaluate the Effects of Cytochrome P450 (CYP) 3A4 Inducer Carbamazepine on Tavapadon Pharmacokinetics in Healthy Adult Participants
Condition: Parkinson Disease Interventions: Drug: Tavapadon; Drug: Carbamazepine Sponsor: Cerevel Therapeutics, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2022 Category: Research Source Type: clinical trials